The Relationship Between Time to Surgery (TTS) and Survival in Breast Cancer: A Systematic Review and Meta-Analysis

Overview

Journal Iran J Public Health

Date 2021 Nov 1

PMID 34722372

Citations 4

Authors

Yongcheng Su

Xiaogang Zheng

Zhong Ouyang

Affiliations

Soon will be listed here.

Abstract

Background: Curative operation is the practical and primary therapy for masses of breast cancers. In contrast, the correlation between the time interval from breast cancer diagnosis to curative surgery and survival is still uncertain.

Methods: An electronic literature search was conducted on PubMed/Medline and EMBASE (between Jan 2000 and Jan 2020). Primary endpoints were overall survival (OS) or Disease-Free Survival (DFS). The HR with 95% confidence intervals were calculated using a random-effects or fixed-effects model.

Results: The combined HR for OS was 1. 10 (95% CI 1. 08-1. 11; =0. 000) by fixed-effects model, no statistically significant heterogeneity was found (=1. 000; I2=0%), and this difference was statistically significant (Z=11. 99; =0. 000).

Conclusion: This meta-analysis showed a significant adverse association between more prolonged time to surgery (TTS) and lower overall survival in patients with breast cancer. It is reasonable to minimize that interval between diagnosis and curative surgery.

Citing Articles

Wait times and breast cancer survival: a population-based retrospective cohort study using CanIMPACT data.

Walsh R, Lofters A, Groome P, Moineddin R, Krzyzanowska M, Griffiths R Cancer Causes Control. 2024; 35(9):1245-1257.

PMID: 38748276 DOI: 10.1007/s10552-024-01879-z.

Efficacy and safety of fibrin sealant application in patients undergoing thyroidectomy: a systematic review and meta-analysis.

Zheng X, Wang F, Su Y, Xu C, Wang M BMC Surg. 2024; 24(1):122.

PMID: 38658932 PMC: 11041004. DOI: 10.1186/s12893-024-02414-2.

Epidemiological and survival outcomes of neuroendocrine carcinoma of the breast: a SEER data analysis.

Xia L, Lai J, Liu X, Kong F, Qiu S, Hu H Transl Cancer Res. 2023; 12(8):1951-1962.

PMID: 37701099 PMC: 10493786. DOI: 10.21037/tcr-23-368.

Second Opinions in Breast Cancer Surgery: What Have We Learned?.

Beer M, Allison H, Fisher C, Fan B Cureus. 2022; 14(10):e30180.

PMID: 36397917 PMC: 9648675. DOI: 10.7759/cureus.30180.

References

Lyons T, Traina T . Emerging Novel Therapeutics in Triple-Negative Breast Cancer. Adv Exp Med Biol. 2019; 1152:377-399. DOI: 10.1007/978-3-030-20301-6_20. View

Churilla T, Egleston B, Murphy C, Sigurdson E, Hayes S, Goldstein L . Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient. Breast Cancer Res Treat. 2016; 160(1):153-162. PMC: 5064835. DOI: 10.1007/s10549-016-3982-x. View

Peto R, Davies C, Godwin J, Gray R, Pan H, Clarke M . Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet. 2011; 379(9814):432-44. PMC: 3273723. DOI: 10.1016/S0140-6736(11)61625-5. View

Raphael M, Biagi J, Kong W, Mates M, Booth C, Mackillop W . The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2016; 160(1):17-28. DOI: 10.1007/s10549-016-3960-3. View

Eriksson L, Bergh J, Humphreys K, Warnberg F, Tornberg S, Czene K . Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population-based cohort study. Int J Cancer. 2018; 143(5):1093-1104. DOI: 10.1002/ijc.31411. View

Mateo A, Mazor A, Obeid E, Daly J, Sigurdson E, Handorf E . Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes. Ann Surg Oncol. 2019; 27(5):1679-1692. PMC: 7145740. DOI: 10.1245/s10434-019-08050-y. View

Polverini A, Nelson R, Marcinkowski E, Jones V, Lai L, Mortimer J . Time to Treatment: Measuring Quality Breast Cancer Care. Ann Surg Oncol. 2016; 23(10):3392-402. DOI: 10.1245/s10434-016-5486-7. View

Chen Z, King W, Pearcey R, Kerba M, Mackillop W . The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2007; 87(1):3-16. DOI: 10.1016/j.radonc.2007.11.016. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

10.

Kuo W, Hwu L, Wu C, Lee J, Chang C, Liu R . STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer. Theranostics. 2017; 7(3):647-663. PMC: 5327640. DOI: 10.7150/thno.16827. View

11.

Eaglehouse Y, Georg M, Shriver C, Zhu K . Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system. Breast Cancer Res Treat. 2019; 178(2):441-450. DOI: 10.1007/s10549-019-05404-8. View

12.

Mansfield S, Abdel-Rasoul M, Terando A, Agnese D . Timing of Breast Cancer Surgery-How Much Does It Matter?. Breast J. 2017; 23(4):444-451. DOI: 10.1111/tbj.12758. View

13.

Cui L, Fan P, Qiu C, Hong Y . Single institution analysis of incidence and risk factors for post-mastectomy pain syndrome. Sci Rep. 2018; 8(1):11494. PMC: 6068100. DOI: 10.1038/s41598-018-29946-x. View

14.

Zhao J, Dong X, Hu X, Long Z, Wang L, Liu Q . Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis. Sci Rep. 2016; 6:22386. PMC: 4773819. DOI: 10.1038/srep22386. View

15.

Shin D, Cho J, Kim S, Guallar E, Hwang S, Cho B . Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013; 20(8):2468-76. DOI: 10.1245/s10434-013-2957-y. View

16.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

17.

Wagner J, Warneke C, Mittendorf E, Bedrosian I, Babiera G, Kuerer H . Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011; 254(1):119-24. PMC: 4345121. DOI: 10.1097/SLA.0b013e318217e97f. View

18.

Fradet Y, Aprikian A, Dranitsaris G, Siemens R, Tsihlias J, Fleshner N . Does prolonging the time to bladder cancer surgery affect long-term cancer control: a systematic review of the literature. Can J Urol. 2006; 13 Suppl 3:37-47. View

19.

Smith E, Ziogas A, Anton-Culver H . Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013; 148(6):516-23. DOI: 10.1001/jamasurg.2013.1680. View

20.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View